Ivor R. Elrifi
CEO & Executive DirectorDr. Ivor R. Elrifi, Ph.D., J.D., is Chief Executive Officer of Tiziana Life Sciences Ltd from August 19, 2024 and its Executive Director from 2024. Dr. Elrifi is a Member at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. He is co-chairman of the Intellectual Property Section at Mintz Levin. He also is a member of the Policy Committee. Today Ivor advises biotechnology, life sciences and medical device companies, research institutions, universities, hospitals and governments throughout the world. He works with clients in several European countries, including Ireland, the U.K., Denmark, Germany and Switzerland. Ivor's practice includes patent prosecution, litigation, arbitration, licensing and transactional work. Ivor assists clients in developing and implementing worldwide patent strategies and in the prosecution and licensing of patents themselves. He is advising a number of leading genomics and proteomics companies located inside and outside the U.S. Ivor also becomes involved in transactional work for clients. He assists in conducting due diligence investigations with respect to investments, mergers and acquisitions. He has extensive experience in representing plaintiffs and defendants in patent litigation and arbitration cases. Ivor has recently lectured at Brown University, Harvard Medical School and the Center for Gene Therapy and Surgical Research, Switzerland. He has also spoken at numerous international conferences and has written articles for leading legal and scientific publications. One of his most recent articles concerned genetically modified foods. He was a prominent panelist at the BIO2000 world conference held in the U.S. Before joining Mintz Levin, Ivor was associated with the intellectual property law firm of Fish & Neave in New York. Later, he served as patent counsel and then general counsel and vice president for CytoTherapeutics, Inc., in Providence, Rhode Island and as patent counsel to Modex Therapeutics in Lausanne, Switzerland. Ivor is admitted to practice in courts in Massachusetts, California, New York and Ontario, Canada. He is admitted to practice before the Court of Appeals for the Federal Circuit and is registered to practice before the United States Patent and Trademark Office. Ivor received both his B.Sc. (1982) and his Ph.D. in Biology (1986) from Queen's University at Kingston, Canada. He received his LL.B. from Osgoode Hall Law School in Toronto, Ontario (1989).
Positions
- Company NameTiziana Life Sciences LtdStock CodeTLSAPositionCEO & Executive DirectorColleagues
- GMGabriele Marco Antonio CerroneFounder & Executive Chairman
- KSKeeren ShahCOO & CFO
- WEWilliam Edward TenteChief Regulatory Officer
- RKRichard K. KimChief Medical Officer
- NFNapoleone FerraraMember of Scientific Advisory Board
- WJWilly Jules SimonIndependent Non-Executive Director
- JPJohn Patrick BrancaccioIndependent Non-Executive Director
